Children and Young adults – The Scientific Advisory Board notes that a remarkable feature of the COVID-19 reports worldwide, is that children and healthy young adults have generally had mild disease and have recovered well.
Patients with previous Kawasaki Disease – Patients with previous Kawasaki Disease have normal immune responses to all common infections, and so there is no reason to suspect that they are any more susceptible to COVID-19 infection. There is also no reason to suspect they will suffer a more severe COVID-19 infection than other children or young adults of similar age. As noted above, research suggests that children and young adults generally have mild disease.
Children and young people 18 years and under taking aspirin – If you are 18 or under, or you have a young child taking aspirin and you/they develop a fever, follow the advice you will already have been given. Please note that advice on aspirin and fever may vary dependent on individual patient circumstances and your doctor will be able to explain more about the particular advice you/your child is given. If you are concerned, speak to your usual doctor (by telephone).
If you/your child is being treated with immunosuppressants or steroids (such as anakinra, infliximab, prednisolone) for acute treatment of Kawasaki Disease their doctors should be informed of both their recent Kawasaki Disease and any medication they are taking, if they develop infection.
If you/your child has been treated in the last 6 months with immunosuppressants or steroids following Kawasaki Disease (such as anakinra, infliximab, prednisolone) their doctors should be informed of both their recent Kawasaki Disease and the medication taken in the last 6 months, if they develop infection.
If you/your child is being treated with other medication for the treatment of Kawasaki Disease, their doctors should be informed if they develop infection.
Patients with existing giant coronary artery aneurysms – Following Kawasaki Disease, patients with existing giant coronary artery aneurysms, or severe cardiac or vascular damage may be more at risk of cardiac complications during any infection. You should inform the medical team looking after you/your child of giant coronary artery aneurysms and severe cardiac damage from Kawasaki Disease, if you/your child develops fever or illness from COVID-19. You should also consult your cardiac team if chest pain or breathlessness develop.
Patients issued with a PSP – If you have a PSP (patient specific protocol), or you are the parent of a child with a PSP you should inform your medical team and make sure that they have access to your PSP and detailed medical history, if you develop infection.
Treatment and vaccine – At the current time there is no vaccine or specific treatment for this infection. NHS advice on treatment when staying at home can be found here
https://www.nhs.uk/conditions/corona...lation-advice/